Largest Review of Its Kind Associates Anti-inflammatory Drugs with Reduced Breast Cancer Risk

Analysis of data from 38 studies that enrolled more than 2.7 million women -- the largest of its kind -- by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute, and the University of Santiago de Compostela reveals that regular use of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) is associated with a 12 per cent relative risk reduction in breast cancer compared to non-users. Comment: But how many women will opt to take a mediation that is not without side effect on a lifetime basis?